Clinical Characterization and Treatment Patterns for the Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease with Severe or Very Severe Airflow Limitation

References

• Hillas G, Perlikos F, Tsiligianni I, Tzana N. Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis 2015; 10(1):95–109.
   PubMed Web of Science ®Google Scholar
• Negewo N, Gibson P, McDonald V. COPD and its comorbidities: impact, measurement and mechanisms. Respirology 2015; 20(8):1160–1171.
   PubMed Web of Science ®Google Scholar
• Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2016. Available from: http://www.goldcopd.org/
   Google Scholar
• Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363(12):1128–1138.
   PubMed Web of Science ®Google Scholar
• Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186(2):155–161.
   PubMed Web of Science ®Google Scholar
• Decramer M, Janssens W. Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med 2013; 1(1):73–83.
   PubMed Web of Science ®Google Scholar
• Faner R, Cruz T, López-Giraldo A, Agustí A. Network medicine, multimorbidity and the lung in the elderly. Eur Respir J 2014; 44(3):775–788.
   PubMed Web of Science ®Google Scholar
• Guarascio AJ, Ray SM, Finch CK, Self TH. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res 2013; 17(5):235–245.
   Google Scholar
• Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med 2009; 7(4):357–363.
   PubMed Web of Science ®Google Scholar
• Fumagalli G, Fabiani F, Forte S, Napolitano M, Balzano G, Bonini M, et al. INDACO project: COPD and link between comorbidities, lung function and inhalation therapy. Multidiscip Respir Med 2015; 10(1):4.
   PubMedGoogle Scholar
• Müllerová H, Shukla A, Hawkins A, Quint J. Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study. BMJ Open 2014; 4(12):e006171.
   PubMed Web of Science ®Google Scholar
• Gu S, Li R, Leader JK, Zheng B, Bon J, Gur D, et al. Obesity and extent of emphysema depicted at CT. Clin Radiol 2015; 70(5):e14–e19.
   Google Scholar
• Wan ES, Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, et al. Genome-wide association analysis of body mass in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2011; 45(2):304–310.
   PubMed Web of Science ®Google Scholar
• Jose J, Escobar A, Bashir M, Claes D. Abnormal rv/tlc ratio is a better criterion to diagnose obstruction in patients with asthma. Chest 2011; 140( 4_MeetingAbstracts):226A.
   Google Scholar
• Richter DC, Joubert JR, Nell H, Schuurmans MM, Irusen EM. Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma. Int J Chron Obstruct Pulmon Dis 2008; 3(4):693–699.
   PubMedGoogle Scholar
• Calverley PMA, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58(8):659–664.
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Celli B, Decramer M, Liu D, Burkhart D, Cassino C, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J 2008; 31(4).
   PubMed Web of Science ®Google Scholar
• Sorino C, D'Amato M, Steinhilber G, Patella V, Corsico AG. Spirometric criteria to diagnose airway obstruction in the elderly: fixed ratio vs. lower limit of normal. Minerva Med 2015; 14(1).
   Google Scholar
• Haruna A, Muro S, Nakano Y, Ohara T, Hoshino Y, Ogawa E, et al. CT scan findings of emphysema predict mortality in COPD. Chest 2010; 138(3):635–640.
   PubMed Web of Science ®Google Scholar
• Tsushima K, Sone S, Fujimoto K, Kubo K, Morita S, Takegami M, et al. Identification of occult parechymal disease such as emphysema or airway disease using screening computed tomography. COPD 2010; 7(2):117–125.
   PubMedGoogle Scholar
• Paul A, Agusti A, Edwards L, Tal-Singer R, Yates J, Bakke P, et al. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease. Thorax 2012; 67(8):701–708.
   PubMed Web of Science ®Google Scholar
• Burgel PR, El Azzi G, Le Gros V, Deslée G. Short-acting bronchodilator reversibility does not predict the response to long-term treatment by indacaterol 150 µg in COPD: REVERBREZ study. Eur Respir J 2013; 42(57):693–699.
   Google Scholar
• Diaz AA, Bartholmai B, San José Estépar R, Ross J, Matsuoka S, Yamashiro T, et al. Relationship of emphysema and airway disease assessed by CT to exercise capacity in COPD. Respir Med 2010; 104(8):1145–1151.
   PubMed Web of Science ®Google Scholar
• Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson LJ, Loscalzo J, et al. Harrison's Principles of Internal Medicine, 17th ed. New York, NY: McGraw Hill, 2009.
   Google Scholar
• Miravitlles M, Guerrero T, Mayordomo C, Sánchez-Agudo L, Nicolau F, Segú JL. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. Respiration 2000; 67(5):495–501.
   PubMed Web of Science ®Google Scholar
• Niewoehner DE, Lokhnygina Y, Rice K, Kuschner WG, Sharafkhaneh A, Sarosi GA, et al. Risk indexes for exacerbations and hospitalizations due to COPD. Chest 2007; 131(1):20–28.
   PubMed Web of Science ®Google Scholar
• Laurin C, Moullec G, Bacon SL, Lavoie KL. The impact of psychological distress on exacerbation rates in COPD. Ther Adv Respir Dis 2011; 5(1):3–18.
   PubMedGoogle Scholar
• Xu W, Collet JP, Shapiro S, Lin Y, Yang T, Platt RW, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med 2008; 178(9):913–920.
   PubMed Web of Science ®Google Scholar
• Patel AR, Kowlessar BS, Donaldson GC, Mackay AJ, Singh R, George SN, et al. Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 188(9):1091–1099.
   PubMed Web of Science ®Google Scholar
• Joo MJ, Lee TA, Weiss KB. Geographic variation in chronic obstructive pulmonary disease exacerbation rates. J Gen Intern Med 2007; 22(11):1560–1565.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Wedzicha JA. The causes and consequences of seasonal variation in COPD exacerbations. Int J Chron Obstruct Pulmon Dis 2014; 9(1):1101–1110.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC). Prim Care Respir J 2013; 22(1):117–121.
   PubMedGoogle Scholar